Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 50010937
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50092126BDBM50092126(2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-3-[(3-p...)
Affinity DataIC50: 1nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100358BDBM50100358((S)-3-[(3-Pyridin-4-yl-3-aza-spiro[5.5]undecane-9-...)
Affinity DataIC50: 1nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100365BDBM50100365((S)-2-Benzyloxycarbonylamino-3-[(3-pyridin-4-yl-3-...)
Affinity DataIC50: 2nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100360BDBM50100360((S)-2-(Butane-1-sulfonylamino)-3-[(3-pyridin-4-yl-...)
Affinity DataIC50: 3nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100376BDBM50100376((S)-2-Butoxycarbonylamino-3-[(3-pyridin-4-yl-3-aza...)
Affinity DataIC50: 8nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100363BDBM50100363(3-{[3-(4-Carbamimidoyl-phenyl)-3-aza-spiro[5.5]und...)
Affinity DataIC50: 60nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100369BDBM50100369((3-Pyridin-4-yl-3-aza-spiro[5.5]undec-9-ylamino)-a...)
Affinity DataIC50: 160nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100362BDBM50100362([9-(4-Cyclohexyl-piperidine-1-carbonyl)-3-aza-spir...)
Affinity DataIC50: 250nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100372BDBM50100372((3-Pyridin-4-yl-3-aza-spiro[5.5]undec-9-yloxy)-ace...)
Affinity DataIC50: 250nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100373BDBM50100373(4-[(3-Pyridin-4-yl-3-aza-spiro[5.5]undecane-9-carb...)
Affinity DataIC50: 319nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100370BDBM50100370(3-Methyl-4-[(3-pyridin-4-yl-3-aza-spiro[5.5]undeca...)
Affinity DataIC50: 332nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100374BDBM50100374([9-(4-Pyridin-4-yl-piperazine-1-carbonyl)-3-aza-sp...)
Affinity DataIC50: 364nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100368BDBM50100368((S)-3-[(3-Pyridin-4-yl-3-aza-spiro[5.5]undecane-9-...)
Affinity DataIC50: 616nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100371BDBM50100371((S)-2-Amino-3-[(3-pyridin-4-yl-3-aza-spiro[5.5]und...)
Affinity DataIC50: 830nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100379BDBM50100379(3-[9-([4,4']Bipiperidinyl-1-carbonyl)-3-aza-spiro[...)
Affinity DataIC50: 2.40E+3nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100364BDBM50100364(3-[9-(4-Pyridin-4-yl-piperazine-1-carbonyl)-3-aza-...)
Affinity DataIC50: 3.45E+3nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100377BDBM50100377(4-{[3-(4-Carbamimidoyl-phenyl)-3-aza-spiro[5.5]und...)
Affinity DataIC50: 5.00E+3nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100359BDBM50100359({[3-(4-Carbamimidoyl-benzoyl)-3-aza-spiro[5.5]unde...)
Affinity DataIC50: 9.70E+3nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100367BDBM50100367(3-(4-Carbamimidoyl-benzoyl)-3-aza-spiro[5.5]undeca...)
Affinity DataIC50: 1.50E+4nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100375BDBM50100375((R)-3-Phenyl-3-[(3-pyridin-4-yl-3-aza-spiro[5.5]un...)
Affinity DataIC50: 3.00E+4nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100366BDBM50100366(3-(3-Pyridin-4-yl-3-aza-spiro[5.5]undec-9-ylamino)...)
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100361BDBM50100361(5-[9-([4,4']Bipiperidinyl-1-carbonyl)-3-aza-spiro[...)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50100378BDBM50100378(4-[9-([4,4']Bipiperidinyl-1-carbonyl)-3-aza-spiro[...)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro inhibitory activity against blockage of binding of fibrinogen to purified human GPIIbIIIaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed